Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt 15mg, tirzepatide reaches its maximum licensed dose in the UK — and for many people, that means both the strongest appetite suppression and the highest likelihood of noticing side effects. The Mounjaro 15mg side effects profile is broadly similar to earlier doses: nausea, digestive discomfort and fatigue lead the list. What shifts is intensity and frequency. In the SURMOUNT-1 trial, side effects were most commonly reported during dose increases rather than once a stable dose was established, so if you've reached 15mg after months of gradual titration, your body has already done a lot of adapting. These are prescription-only medicines; a GPhC-registered prescriber assesses your suitability and supports you through any side effects as part of ongoing care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's a Tuesday morning, the same routine as every injection day for the past four months. But this pen is different, it's the 15mg KwikPen, the ceiling of what the Mounjaro schedule allows. For most people who reach this point, the move from 12.5mg to 15mg is the one they've been building towards, and the body's response is usually milder than the jump from 2.5mg to 5mg at the very beginning. That's because titration does real work. The slow, prescriber-guided increase through earlier doses gives your digestive system time to adapt to tirzepatide's effect of slowing gastric emptying, meaning food sits in the stomach longer, which is why nausea is the most common complaint.
At 15mg specifically, clinical trial data shows that nausea, vomiting, diarrhoea and constipation remain the leading side effects, and you can read a full breakdown on our Mounjaro 15mg side effects page. Fatigue, burping, acid reflux and mild dizziness are also reported. The NHS tirzepatide medicines page lists these in full and is worth bookmarking for reference. Most symptoms ease within days to two weeks of a dose change as the body adjusts. Eating smaller portions, avoiding very fatty or rich meals, and staying well hydrated all make a practical difference, advice our prescribers discuss as standard during clinical review.
For a sense of how the side-effect picture evolves across the schedule, the experience at the 2.5mg starting dose reads very differently to this point, which reflects how much individual tolerance can develop over a full titration course.
Most Mounjaro 15mg side effects are uncomfortable rather than dangerous, and they pass. But some symptoms are signals that something more serious may be happening, and those deserve a clear, direct list.
Get urgent medical help (call 111 or go to A&E) if you develop severe, persistent abdominal pain that may spread towards the back, with or without vomiting. This can indicate acute pancreatitis, which is a known but infrequent risk with GLP-1 and dual GIP/GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a reason to stop treatment and seek immediate care. The same applies to symptoms of a severe allergic reaction: swelling of the face, throat or tongue, difficulty breathing, or a spreading rash.
Gallbladder problems (including gallstones) are also associated with significant, rapid weight loss in general, and with GLP-1 receptor agonists specifically. Sudden pain in the upper-right abdomen, particularly after eating, warrants a call to your GP or 111. Prolonged vomiting or diarrhoea that stops you keeping fluids down is a dehydration risk and can affect kidney function; don't wait more than 24 hours to get advice if that's happening.
If you experience changes in mood, low mood or thoughts of self-harm, contact your prescriber or GP promptly. And if you notice any reaction that concerns you and isn't listed here, report it to the MHRA via the Yellow Card scheme, that reporting system is how post-market safety signals are caught and acted on. You can report as a patient, not just as a clinician.
Our prescribers are available seven days a week for aftercare questions. The contact page is the fastest route if something doesn't feel right between injection days.
One question that comes up regularly: are there side effects that only emerge at 15mg, or does the pattern simply intensify? The honest answer is mostly the latter. Tirzepatide's mechanism (activating both GIP and GLP-1 receptors, slowing gastric emptying and reducing appetite signals) doesn't change at 15mg. The pharmacology is the same; the dose is higher.
What does sometimes appear or worsen at the ceiling dose is injection-site reactions: redness, mild swelling or itching at the injection site. Rotating sites between the abdomen, thigh and upper arm helps considerably. Hair thinning is reported by some patients during significant weight-loss phases and is generally related to the caloric and nutritional change rather than the medicine itself, it tends to resolve as intake stabilises and protein adequacy improves. Our 10mg Mounjaro side effects page and the profile at 7.5mg cover the mid-range experience in more detail, and comparing them can help you understand what's genuinely dose-related versus what was already present earlier in the titration. You may also find it useful to look back at what side effects are typical at 5mg, to see how far your tolerance has come since the early weeks.
Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA requires additional monitoring as longer-term real-world data accumulates. That's standard for newer medicines and doesn't reflect an unusual safety concern, but it is one reason why clinical oversight throughout treatment matters, not just at the point of starting. The BNF tirzepatide entry gives the professional-level summary of contraindications and cautions if you'd like the clinical reference to hand.
Reaching 15mg usually means you've been on tirzepatide for at least five to six months. At nume, every repeat order goes through fresh clinical review before it's dispensed, a real prescriber, not an automated process, reads the updated information and confirms that continuing is appropriate. That review includes your current side-effect experience, any new symptoms, and whether the dose is still working well for you.
If 15mg side effects are making treatment very difficult to tolerate, the prescriber may suggest a temporary hold or discuss whether a lower maintenance dose is more sustainable long-term. That's a clinical decision made with you, not a one-size response. Details of our clinical team and how prescribing decisions are made are on the clinical team page.
For anyone who hasn't yet started and is trying to understand the full side-effect picture before making a decision, the free consultation is the right starting point. Our prescribers discuss suitability, likely experience at each dose level, and any personal health factors that change the picture, all before any treatment is prescribed or dispensed. There's no obligation to proceed, and the conversation is clinically led throughout.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.